Skip to main
University-wide Navigation

Kentucky Cancer Registry Awarded Multimillion-dollar Contract from NCI

The Kentucky Cancer Registry (KCR) has received a $2.6 million contract from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results (SEER) program.

Winning Students Meet Cancer Researchers in 'Pennies for Patients' Contest

The University of Kentucky Markey Cancer Center and Leukemia and Lymphoma Society (LLS) recently hosted three regional schools for the seventh annual “Meet the Researchers Day.”

Annual KCSP Conference Honors Smoke-free Advocates Across Kentucky

The annual spring conference of the Kentucky Center for Smoke-free Policy connected health advocates from across Kentucky to discuss how to promote smoke-free environments, and honor advocates for their work in making their communities and schools healthier.

Study: Two Drugs Prevent Heart Failure in Breast Cancer Patients

Dr. Maya Guglin presented data that shows adding beta blockers or ACE inhibitors to a chemotherapy regimen for patients with HER2-positive breast cancer significantly reduces cardiotoxicity.

Training Kentucky's Next Generation of Cancer Fighters

CTOP is educating and empowering UK undergrads, from Kentucky’s Appalachian counties, through hands-on cancer research, clinical observation and shadowing, classroom and workshop learning, and community outreach in the participants’ own towns and neighborhoods.

St. Elizabeth Healthcare Joins Markey Affiliate Network

St. Elizabeth Healthcare announced Friday that it has joined the Markey Cancer Center Affiliate Network, further expanding its relationship with the University of Kentucky.

Sally Ellingson Uses Big Data & Machine Learning to Improve Drug Development

With the Markey Cancer Center, Ellingson uses molecular docking as a filtering process to efficiently and safely screen potential drugs before real-world experiments begin.

New Study Shows Repurposing Leukemia Drugs May Prevent Melanoma Metastasis

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

Markey Launches Precision Medicine Clinic, Expands Catalog of Early Phase Clinical Trials

In its ongoing efforts to offer Kentuckians the latest, most innovative cancer treatments available, the UK Markey Cancer Center recently launched the Precision Medicine Clinic, a new space dedicated to providing patients with increased access to phase I and phase II clinical trials.

Join 'Markey Women Strong' to Advance Cancer Research at UK

The Markey Cancer Foundation invites you to take an active role in furthering life-changing cancer research at the University of Kentucky Markey Cancer Center through the 'Markey Women Strong' program.

Filter News

Type of news story
UK Research Unit
news topic
Research news series